Find trials
Search tips

CSF-venous Fistula (CVF) Beta Trace Protein Venous Blood Levels

Overview

About this study

The purpose of this study is to compare Beta Trace Protein venous blood levels in those with and without  CSF-venous fistula (CVF), and to create a proof of concept that Beta Trace Protein is a feasible blood test for patients with CVF.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • English speaking subjects with a suspected CVF, known CVF, or healthy control subjects.

Exclusion Criteria: 

  • Subjects who are not English speaking.

Eligibility last updated 8/22/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ian Mark, M.D., MSM

Open for enrollment

Contact information:

Suson Walsh CCRP

Walsh.Suson@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20544526

Mayo Clinic Footer